Phio Pharmaceuticals Corp Stock Today
| PHIO Stock | USD 2.95 0.30 9.23% |
Performance6 of 100
| Odds Of DistressLess than 9
|
Phio Pharmaceuticals is selling at 2.95 as of the 8th of November 2024; that is 9.23% down since the beginning of the trading day. The stock's open price was 3.25. Phio Pharmaceuticals has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. Equity ratings for Phio Pharmaceuticals Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 10th of August 2024 and ending today, the 8th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 10th of May 2012 | Category Healthcare | Classification Health Care |
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. Phio Pharmaceuticals Corp. was incorporated in 2011 and is headquartered in Marlborough, Massachusetts. Phio Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 860.72 K outstanding shares of which 21.34 K shares are at this time shorted by private and institutional investors with about 0.3 trading days to cover. More on Phio Pharmaceuticals Corp
Moving against Phio Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Phio Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Chairman | Robert Bitterman | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsPhio Pharmaceuticals can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Phio Pharmaceuticals' financial leverage. It provides some insight into what part of Phio Pharmaceuticals' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
Phio Pharmaceuticals Corp (PHIO) is traded on NASDAQ Exchange in USA. It is located in 11 Apex Drive, Marlborough, MA, United States, 01752 and employs 8 people. Phio Pharmaceuticals is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.8 M. Phio Pharmaceuticals Corp conducts business under Biotechnology sector and is part of Health Care industry. The entity has 860.72 K outstanding shares of which 21.34 K shares are at this time shorted by private and institutional investors with about 0.3 trading days to cover.
Phio Pharmaceuticals Corp currently holds about 18.02 M in cash with (10.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.32.
Check Phio Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationPhio Pharmaceuticals holds 5.89 pct. of its outstanding shares held by insiders and 2.44 pct. owned by third-party entities.
Check Phio Ownership Details
Phio Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Wells Fargo & Co | 2024-06-30 | 0.0 | |
| Bank Of Montreal | 2024-06-30 | 0.0 | |
| Virtu Financial Llc | 2024-06-30 | 0.0 | |
| Bmo Capital Markets Corp. | 2024-06-30 | 0.0 |
Phio Pharmaceuticals Historical Income Statement
Phio Stock Against Markets
Phio Pharmaceuticals Corporate Management
| Jim Cardia | VP Operations | Profile | |
| Caitlin Kontulis | VP Secretary | Profile | |
| Dr MedSc | Interim Director | Profile | |
| Linda Mahoney | Senior Development | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phio Pharmaceuticals Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phio Pharmaceuticals. If investors know Phio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (16.08) | Return On Assets (0.61) | Return On Equity (1.27) |
The market value of Phio Pharmaceuticals Corp is measured differently than its book value, which is the value of Phio that is recorded on the company's balance sheet. Investors also form their own opinion of Phio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Phio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Phio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Phio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.